Metabolic-Only Criteria in Pediatric High-Risk (HR) cHL: A Review of Reduced Radiotherapy (RT) Exposure in HLHR13 and cHOD17 Trials

John T. Lucas(Wake Forest University), Matthew J. Ehrhardt(St. Jude Children's Research Hospital), H Weinstein(Massachusetts General Hospital), Torunn I. Yock(Massachusetts General Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Jonathon Blake(St. Jude Children's Research Hospital), Stephan D. Voss(Brigham and Women's Hospital), Jamie E. Flerlage(St. Jude Children's Research Hospital), Nickhill Bhakta(St. Jude Children's Research Hospital), Yinmei Zhou(St. Jude Children's Research Hospital), Shannon M. MacDonald(Massachusetts General Hospital), Barry L. Shulkin(St. Jude Children's Research Hospital), Matthew Rees(St. Jude Children's Research Hospital), Zachary Abramson(St. Jude Children's Research Hospital), Simon Dixon(Beaumont Hospital, Royal Oak), Leon J. Marks(Stanford Medicine), Alessandra Feraco(Vita-Salute San Raffaele University), Hesham Elhalawani(The University of Texas MD Anderson Cancer Center), Christopher R. Bolen(Yale University), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), Ying Zheng(Chinese People's Liberation Army), A. Friedmann(Massachusetts General Hospital), B. E. Roberts(St. Jude Children's Research Hospital), Karen Marcus(Boston Children's Museum), Michael P. Link(Stanford University), Sue C. Kaste(St. Jude Children's Research Hospital), Dinar Sawant(St. Jude Children's Research Hospital), Susan M. Hiniker(Stanford University), L Wileman(St. Jude Children's Research Hospital), P De Alarcon(Illinois College)
Klinische Pädiatrie
December 1, 2025
Cited by 0


Related Papers